Catastrophic antiphospholipid syndrome and heparin-induced thrombocytopenia-related diseases or chance association?. Issue 2 (March 2015)

• Record Type: Journal Article
• Authors: Tun, Nay T.; Krishnamurthy, Mahesh; Snyder, Richard
• Is Part Of: Blood coagulation and fibrinolysis. Volume 26:Issue 2(2015)
• Publication Date: 2015-03
• Subjects: Blood -- Coagulation -- Periodicals; Fibrinolysis -- Periodicals; Hemostasis -- Periodicals; Thrombosis -- Periodicals; Blood Coagulation -- Periodicals; Fibrinolysis -- Periodicals; Hemostasis -- Periodicals; Thrombosis -- Periodicals; 612.115
• DOI: 10.1097/MBC.0000000000000210
• Languages: English
• ISSNs: 0957-5235

Abstract

<abstract> <title> <x xml:space="preserve">Abstract</x> </title> <sec> <p>Antiphospholipid syndrome (APS) and heparin-induced thrombocytopenia (HIT) are thrombotic disorders due to specific autoimmune-mediated antibodies. Catastrophic APS (CAPS), also known as Asherman's syndrome, is a life-threatening severe form of APS. Diagnostic criteria for CAPS include the development of a thrombotic event of three or more organs in less than a week with the presence of antiphospholipid antibodies and microvascular thrombosis on histology. Thrombocytopenia is seen in more than 60% of cases of CAPS. HIT is a life-threatening disorder with the clinical presentation of thrombocytopenia and arterial or venous thrombosis in patients who develop antibodies to heparin and platelet factor 4 typically within 10 days after starting heparin treatment. Due to the multiple similarities in clinical features and pathophysiology of CAPS and HIT, it has been postulated that these two antibody-mediated disorders may be related. We report two cases in which patients diagnosed with CAPS developed HIT very soon during the same admission as well as a case of a patient initially diagnosed with HIT who presented with CAPS years later.</p> </sec> </abstract>